Arsenal Biosciences, Inc. (ArsenalBio)

ArsenalBio

The company develops programmable T cell therapies for patients with solid tumours and autoimmune diseases.

Engimmune Therapeutics

This deep-tech company develops soluble T-cell receptor drugs for healthcare providers to treat patients with solid tumour cancers and immune-mediated diseases.

3T Biosciences

The company develops T-cell receptor therapeutics and target identification technologies for oncology patients to treat solid tumours.

Cartography Biosciences

This deep-tech company develops precision cancer therapeutics and drug targets for healthcare providers using computational biology and machine learning platforms.

Modulari-T Biosciences

This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.

Seismic Therapeutic

The company develops immunology therapies for autoimmune and allergic diseases using machine learning for biologics discovery in the deep-tech sector.

Strand Therapeutics

This biotechnology company develops programmable messenger RNA therapies for patients with solid tumours and autoimmune diseases.

GC Therapeutics

This deep-tech company develops a cell programming platform to produce off-the-shelf medicines for patients with gastrointestinal, neurological and immunological diseases.